References
- References
- Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci 1998;43: 2463–9.
- Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, et al. Randomised trial of transjugular intrahepatic portosystemic shunt versus endoscopy plus propa- nolol for prevention of variceal rebleeding. Lancet 1997;349:1043–9.
- Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 1998;28:683–8.
- Ochs A, Rössle M, Haag K, Hauenstein K-H, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192–7.
- Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829–35.
- Bories P, Garcia Compean D, Michel H, Bourel M, Capron JP, Gauthier A, et al. The treatment of refractory ascites by the LeVeen shunt: a multicenter controlled trial. J Hepatol 1986;3:212–8.
- Somberg K, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709–16.
- Deschenes M, Dufresne M-P, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361–5.
- Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Foshager MC, Ferral H, et al. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173–80.
- Crenshaw WB, Gordon FD, McEniff NJ, Perry LJ, Hartnell G, Anastopoulos H, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200:185–192.
- Arroyo V, Gines P, Gerbes AL, Dudley F, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164–76.
- Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia- Villarreal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effects on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:986–94.
- Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135–44.
- Eckardt KU. Renal failure in liver disease. Intensive Care Med 1999;25:5–14.
- Nicholls KM, Shapiro MD, Van Putten VJ, Kluge R, Chung HM, Bichet DG, et al. Elevated plasma norepinephrine concentrations in decompensated cirrhosis: association with increased secretion rates, normal clearance rates and suppres- sibility by central blood volume expansion. Circ Res 1985;56:457–61.
- Wong F, Sniderman K, Liu P, Allindina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816–22.
- Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998;28:416–22.
- Ochs A, Rössle M, Haag K, Gerbes AL, Morgenroth A, Deibert P, et al. TIPS for hepatorenal syndrome. Hepatology 1994;20: 114A.
- Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T. Transjugular intrahepatic portosystemic stentshunt for hepatorenal syndrome. Lancet 1997;349:697–8.